Tune Therapeutics, an epigenome-editing company based in Durham and Seattle, will be the first to initiate a human clinical trial for an epigenetic therapy for a common infectious disease.
"Brain areas involved in processing numbers can be delineated and extra care taken to avoid damaging these areas during neurosurgical interventions," said lead author Alexander Rockhill, Ph.D., a ...
A group of young students became bonafide biomedical scientists before they even started high school. Through a partnership with a nearby university, the middle schoolers collected and analyzed ...